Elizabeth Holmes’s Social Media Feed Hits Different After Watching ‘You Can See Everything’
THE SO WHAT
Cultural re-litigation of the Theranos story keeps founder myth-making and fraud top-of-mind for investors and regulators. If you’re raising for complex tech, expect deeper diligence on claims and a lower tolerance for 'trust me' narratives.
READ THE SOURCE
MORE FROM THE WIRE
Tech & InnovationJust when we thought targeted ads couldn't get any worse, these were found serving malware
Adtech is now a software supply chain risk surface, not just a privacy problem—targeted inventory that can be weaponized against specific cohorts collapses the gap between marketing and intrusion. If you’re running programmatic campaigns or ad-funded products, treat ad networks like third-party code: tighten allowlists, instrument monitoring, and assume compromise is possible through the ad slot.
Tech & InnovationSennheiser Accentum Clip open earbuds are elite. There’s just one major issue.
Open-ear audio is maturing into a distinct category, but a single misstep in fit, controls, or availability can stall adoption. If you build around hearables—fitness, comms, assistive—optimize for compatibility across multiple hardware vendors rather than betting on one SKU’s success.
Tech & InnovationJury finds Arm breached its Qualcomm licence, then awards Qualcomm $2
A jury finding breach but awarding $2 in damages is a reminder that IP disputes can drag on without materially reshaping the ecosystem—yet still inject uncertainty into roadmaps. If your products depend on contested IP, track legal outcomes for precedent, not payout size, and keep contingency designs warm.
Tech & InnovationZelenskyy Says Starlink Restrictions on Ukraine Look Deliberate
A head of state accusing a private network provider of deliberate wartime restrictions underscores how much geopolitical leverage now sits in commercial comms stacks. Any operator building on third-party connectivity or cloud for critical services should be modeling political and policy risk alongside SLAs.